The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD.

International Journal of Chronic Obstructive Pulmonary Disease
Barbara P YawnAnand A Dalal

Abstract

Exacerbations contribute significantly to the morbidity of COPD, leading to an accelerated decline in lung function, reduced functional status, reduced health status and quality of life, poorer prognosis and increased mortality. Prevention of exacerbations is thus an important goal of COPD management. In patients with COPD, treatment with a combination of the inhaled corticosteroid fluticasone propionate (250 microg) and the long-acting beta(2)-agonist salmeterol (50 microg) in a single inhaler (250/50 microg) is an effective therapy option that has been shown to reduce the frequency of exacerbations, to improve lung function, dyspnea and health status, and to be relatively cost-effective as a COPD maintenance therapy. Importantly, results of various studies suggest that fluticasone propionate and salmeterol have synergistic effects when administered together that improve their efficacy in controlling symptoms and reducing exacerbations. The present non-systematic review summarizes the role of fluticasone propionate/salmeterol combination therapy in the prevention of exacerbations of COPD and its related effects on lung function, survival, health status, and healthcare costs.

References

May 29, 1998·American Journal of Respiratory and Critical Care Medicine·T A SeemungalJ A Wedzicha
May 12, 2000·American Journal of Respiratory and Critical Care Medicine·T A SeemungalJ A Wedzicha
Jan 3, 2001·The New England Journal of Medicine·UNKNOWN Lung Health Study Research GroupMelissa Skeans
Feb 15, 2001·Chest·S A StrasselsP S Mahajan
Aug 25, 2001·American Journal of Respiratory and Critical Care Medicine·D D Sin, J V Tu
Jun 19, 2002·American Journal of Respiratory and Critical Care Medicine·Keith L HattotuwaNeil C Barnes
Aug 16, 2002·The New England Journal of Medicine·Sanjay SethiTimothy F Murphy
Feb 7, 2003·The European Respiratory Journal·F Di MarcoS Centanni
Feb 14, 2003·Lancet·Peter CalverleyUNKNOWN TRial of Inhaled STeroids ANd long-acting beta2 agonists study group
Jun 11, 2003·The European Respiratory Journal. Supplement·S Burge, J A Wedzicha
Oct 4, 2003·American Journal of Respiratory and Critical Care Medicine·Vincent S FanDavid H Au
Dec 19, 2003·The European Respiratory Journal·G C DonaldsonJ A Wedzicha
Mar 3, 2004·American Journal of Respiratory and Critical Care Medicine·Tom M A WilkinsonJadwiga A Wedzicha
Jun 5, 2004·The European Respiratory Journal·S SpencerP W Jones
Jun 29, 2004·The European Respiratory Journal·B R CelliUNKNOWN ATS/ERS Task Force
Jul 2, 2004·American Journal of Respiratory and Critical Care Medicine·Don D SinS F Paul Man
May 18, 2005·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Mercé PlanasL Reyes
Aug 23, 2005·Proceedings of the American Thoracic Society·Peter M A Calverley
Oct 4, 2005·Respiratory Medicine·Douglas W MapelFloyd J Frost
Jan 21, 2006·American Journal of Respiratory and Critical Care Medicine·Neil C BarnesUNKNOWN SCO30005 Study Group
Jan 31, 2006·Thorax·G C Donaldson, J A Wedzicha
Jun 17, 2006·Chest·David B PriceUNKNOWN COPD Questionnaire Study Group
Oct 21, 2006·American Journal of Respiratory and Critical Care Medicine·Peter KardosClaus Vogelmeier
Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
May 5, 2007·American Journal of Respiratory and Critical Care Medicine·Sanjay SethiTimothy F Murphy

❮ Previous
Next ❯

Citations

Mar 29, 2014·International Journal of Chronic Obstructive Pulmonary Disease·Jeetvan G PatelAnand A Dalal

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
biopsy
X-ray

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.